In the context of a C1-INH deficiency, abnormal activation of complement via the classical pathway consumes the initial components of the cascade and may expose HAE patients to an increased risk of immune-complex disease, as seen in the C2 or C4 deficiencies. The gene discussed is SERPING1; the disease is type III hypersensitivity disease.